pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Psychiatry & CNS · news · pharmadog
← back to Psychiatry & CNS
News · Psychiatry & CNS
440
stories
Aug 14, 26
Nascent US psychedelic therapy opportunity attracts overseas manufacturers
biospace
Aug 13, 26
Opinion: How to disrupt the health misinformation business model
stat
Aug 13, 26
Opinion: I’ve seen what life is like without vaccines. Americans need to understand what they save us from
stat
Aug 13, 26
STAT+: What patients actually think about ‘minimally invasive’ brain implants
stat
Aug 12, 26
Vaping and cannabis hit record highs among young adults in 2025: Survey
stat
Aug 12, 26
STAT+: Cancer patients face longer wait times to begin treatment, according to new study
stat
Aug 12, 26
Opinion: The Lindsay Clancy case shows the limits of postpartum psychiatry
stat
Aug 12, 26
Psychedelics developer Definium scores more positive data for LSD pill
biopharma dive
Aug 12, 26
Definium’s LSD asset beats analyst expectations in Phase 3 anxiety readout
biospace
Aug 12, 26
STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial
stat
Aug 12, 26
Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trials
endpoints
Aug 11, 26
Medicaid will stop paying for some gender-affirming care for transgender minors
stat
Aug 11, 26
Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety
fiercebiotech
Aug 11, 26
STAT+: Skylark Bio kicks off new gene therapy trial for deafness
stat
Aug 10, 26
All eyes on psychedelic drugmakers as Definium, Compass near major catalysts
biospace
Aug 10, 26
Denali climbs past Avlayah expectations with $3.6M in revenue
biospace
Aug 10, 26
Jazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies
fiercebiotech
Aug 10, 26
Psychedelics on the cusp of market breakthrough as clinical, policy support grow
biospace
Aug 7, 26
A third clinic settles with DOJ over trans care
stat
Aug 6, 26
Takeda approval ushers in new wave of sleep drugs
biopharma dive
Aug 6, 26
STAT+: Medicare pushes ACCESS but doesn’t tell patients what providers offer it
stat
Aug 6, 26
Covid can reactivate dormant viruses, according to study
stat
Aug 5, 26
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
stat
Aug 5, 26
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
stat
Aug 5, 26
FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
fda press
Aug 5, 26
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
biospace
Aug 5, 26
The main therapy used for children with autism faces changes under Medicaid
stat
Aug 5, 26
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
Aug 5, 26
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
Aug 5, 26
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
fda medwatch
← prev
page 5 of 15
next →
